TTKN News » Health

FDA provides updated safety data on silicone gel-filled breast implants

Kate Penolope — Thu, 23 Jun 2011 07:09:38 +0000

The U.S. Food and Drug Administration released a report today updating the clinical and scientific information for silicone gel-filled breast implants, including preliminary safety data from studies conducted by the manufacturers as a condition of their November 2006 approval. While the report

FDA: Maryland food manufacturer enters into consent decree

Kate Penolope — Thu, 23 Jun 2011 07:07:33 +0000

The U.S. Food and Drug Administration announced that Sungwon Inc of Columbia, a Columbia, Md., corporation, and the company’s president, Sang Ja Lee, have signed a consent decree of permanent injunction. Prior to entry of the consent decree, defendants manufactured and distributed ready-to-eat

FDA unveils final cigarette warning labels

Kate Penolope — Thu, 23 Jun 2011 07:05:48 +0000

The U.S. Food and Drug Administration (FDA) today unveiled the nine graphic health warnings required to appear on every pack of cigarettes sold in the United States and in every cigarette advertisement. This bold measure will help prevent children from smoking, encourage adults who do to quit,

FDA examines ways to improve consumer understanding of prescription drug ads

Kate Penolope — Tue, 21 Jun 2011 06:25:32 +0000

Findings from three studies conducted by the U.S. Food and Drug Administration confirm that the way information is conveyed and displayed in printed drug advertising affects consumer understanding of prescription medications. The studies, designed by experts in FDA’s Division of Drug,

FDA approves Nulojix for kidney transplant patients

Kate Penolope — Tue, 21 Jun 2011 06:03:48 +0000

The U.S. Food and Drug Administration today approved Nulojix (belatacept) to prevent acute rejection in adult patients who have had a kidney transplant. The drug is approved for use with other immunosuppressants (medications that suppress the immune system) — specifically basiliximab,

FDA approves new test to help determine if breast cancer patients are candidates for Herceptin treatment

Kate Penolope — Tue, 21 Jun 2011 05:56:31 +0000

The U.S. Food and Drug Administration today approved a new genetic test that will help health care professionals determine if women with breast cancer are HER2-positive and, therefore, candidates for Herceptin (trastuzumab), a commonly used breast cancer treatment. The test, called Inform Dual

FDA Announces Changes to Better Inform Consumers About Sunscreen

Kate Penolope — Tue, 21 Jun 2011 05:47:06 +0000

The U.S. Food and Drug Administration announced today that sunscreen products meeting modern standards for effectiveness may be labeled with new information to help consumers find products that, when used with other sun protection measures, reduce the risk of skin cancer and early skin aging, as

FDA Announces Changes to Better Inform Consumers About Sunscreen

Kate Penolope — Tue, 21 Jun 2011 05:46:53 +0000

FDA approves Potiga to treat seizures in adults

Kate Penolope — Tue, 21 Jun 2011 04:53:23 +0000

On June 10, Potiga (ezogabine) tablets were approved by the U.S. Food and Drug Administration for use as an add-on medication to treat seizures associated with epilepsy in adults. Potiga was approved for the treatment of partial seizures, the most common type of seizure seen in people with

14 Health Plans Adopt Microsoft’s Health Plan Sales Solution for Microsoft Dynamics CRM

Kate Penolope — Tue, 21 Jun 2011 03:26:56 +0000

SAN FRANCISCO — June 15, 2011 — Microsoft Corp. today announced at the America’s Health Insurance Plans (AHIP) Institute 2011 that 14 health plans, including Blue Cross of Northeastern Pennsylvania and Blue Cross and Blue Shield of Kansas City, have implemented or are planning to deploy